Durect Corp (DRRX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

10260 BUBB RD CUPERTINO, CA 95014

Develops pharmaceutical systems based on proprietary drug delivery technology platforms: the SABER Delivery System, the TRANSDUR Delivery System, the ORADUR sustained release oral gel-cap technology, the DURIN Biodegradable Implant, the DUROS System, and MICRODUR Biodegradable Microparticulates.

Data as of 2020-07-04
Market Cap439.095 Million Shares Outstanding196.025 Million Avg 30-day Volume2.377 Million
P/E Ratio Dividend Yield EPS-0.13
Price/Sales18.127 Price cash flow ratio107.4 Price free cash flow ratio45.4
Book Value0.07 Price to Tangible Book57.34 Alpha0.02
Short Interest Ratio % Short Interest to Float R-squared0.113058
BETA2.16984 52-week High/Low3.949 / 0.64 Stddev0.274809
View SEC Filings from DRRX instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 3 2 (0.13%)
13F Filers holding this stock: 81 25 (1.64%)
Aggregate 13F shares on 03/31/2020: 97.743 Million 83.395 Million
Aggregate 13F shares on 12/31/2019: 91.871 Million 80.04 Million
Percent change: 6.39% 4.19%
Funds creating new positions: 20 5
Funds Adding to an existing position: 28 11
Funds closing out their position: 13 5
Funds reducing their position: 19 7
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding DRRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DRRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

97.2 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

57.8 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FARFEL GAIL M EVP/CHIEF DEVELOPMENT OFFICER

  • Officer
11,179 2020-06-25 1

LIU JEAN I GC/EVP, LEG AFFAIRS

  • Officer
63,597 2020-06-19 0

HOFFMANN DAVE

  • Director
0 2020-06-17 1

NEUKERMANS ARMAND

  • Director
0 2020-06-17 1

BLASCHKE TERRENCE F

  • Director
0 2020-06-17 1

BENITO SIMON X

  • Director
0 2020-06-17 1

SAXE JON S

  • Director
0 2020-06-17 1

ROBERTSON JUDITH J.

  • Director
0 2020-06-17 1

JOICE JUDY R SR. VP OPERATIONS & CORP QA

  • Officer
32,747 2020-06-03 2

SHEPARD JAY

  • Director
11,073 2020-05-28 0

BLEICHROEDER LP

  • 10% Owner
26,664,656 2020-05-26 3

FIRST EAGLE INVESTMENT MANAGEMENT, LLC

FIRST EAGLE HOLDINGS, INC.

  • 10% Owner
5,004,422 2020-04-17 0

BROWN JAMES E PRESIDENT & CEO

  • Officer
  • Director
0 2020-01-21 1

ARENBERG MICHAEL CHIEF FINANCIAL OFFICER

  • Officer
0 2020-01-21 1

CASEY MICHAEL D

0 2019-11-20 0

FIRST EAGLE INVESTMENT MANAGEMENT, LLC

21 APRIL FUND, L.P.

21 APRIL FUND, LTD.

FIRST EAGLE VALUE IN BIOTECHNOLOGY MASTER FUND, LTD.

FIRST EAGLE HOLDINGS, INC.

  • 10% Owner
26,476,546 2019-06-20 0

STAUFFER JOSEPH WILLIAM CHIEF MEDICAL OFFICER

  • Officer
2,000 2018-10-17 0

THEEUWES FELIX CHAIRMAN AND CSO

  • Officer
  • Director
0 2018-01-26 0

HOGAN MATTHEW J CHIEF FINANCIAL OFFICER

  • Officer
0 2018-01-26 0

21 APRIL FUND, LTD.

21 APRIL FUND, L.P.

FIRST EAGLE VALUE IN BIOTECHNOLOGY MASTER FUND, LTD.

FIRST EAGLE HOLDINGS, INC.

  • 10% Owner
22,381,546 2016-09-26 0

YUM SU IL EXEC. VP PHARM./R&D

  • Officer
0 2015-01-09 0

LANGECKER PETER CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
77,993 2013-08-08 0

MENDENHALL PAULA V EXEC. VP OF OPERATIONS/ADMIN.

  • Officer
0 2012-02-03 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

BLASCHKE TERRENCE F - Director

2020-06-17 A 55,000 a 55,000 0.00 direct

BENITO SIMON X - Director

2020-06-17 A 55,000 a 55,000 0.00 direct

ROBERTSON JUDITH J. - Director

2020-06-17 A 55,000 a 55,000 0.00 direct

SAXE JON S - Director

2020-06-17 A 55,000 a 55,000 0.00 direct

FARFEL GAIL M - Director

2020-06-17 A 55,000 a 55,000 0.00 direct

HOFFMANN DAVE - Director

2020-06-17 A 55,000 a 55,000 0.00 direct

NEUKERMANS ARMAND - Director

2020-06-17 A 55,000 a 55,000 0.00 direct

JOICE JUDY R - Officer SR. VP OPERATIONS & CORP QA

2020-06-03 M 34,864 d 22,956 32,747.00 direct

JOICE JUDY R - Officer SR. VP OPERATIONS & CORP QA

2020-06-03 S 34,864 $2.45 d 32,747 32,747.00 direct

JOICE JUDY R - Officer SR. VP OPERATIONS & CORP QA

2020-06-03 S 22,956 $2.45 d 32,747 32,747.00 direct

JOICE JUDY R - Officer SR. VP OPERATIONS & CORP QA

2020-06-03 M 34,864 $0.78 a 67,611 32,747.00 direct

JOICE JUDY R - Officer SR. VP OPERATIONS & CORP QA

2020-06-03 M 22,956 d 0 32,747.00 direct

JOICE JUDY R - Officer SR. VP OPERATIONS & CORP QA

2020-06-03 M 22,956 $0.78 a 55,703 32,747.00 direct

BLEICHROEDER LP - > 10% Owner see footnote

2020-05-26 S 39,388 $2.50 d 26,664,656 26,664,656.00 indirect
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments